Treatment of Hormonal Acne in Men Due to Testosterone
For men with acne caused by excess testosterone, standard acne treatments should be used first—topical retinoids combined with benzoyl peroxide for mild-moderate cases, and oral isotretinoin for severe or refractory cases—while investigating and addressing any underlying pathologic androgen excess.
Clinical Approach
Initial Assessment and Diagnosis
The key distinction is whether testosterone elevation represents:
- Pathologic hyperandrogenism (congenital adrenal hyperplasia, androgen-secreting tumors)
- Iatrogenic excess (testosterone replacement therapy, anabolic steroid use)
- Normal physiological levels with increased end-organ sensitivity
Important caveat: The available guidelines 1 focus predominantly on hyperandrogenism in women, not men. This reflects that pathologic androgen excess causing acne is far more common in females. In men, acne severity does not correlate directly with serum testosterone levels 2, as end-organ sensitivity varies significantly.
When to Suspect Pathologic Androgen Excess in Men
Investigate for underlying endocrine disorders if acne is accompanied by:
- Severe, treatment-resistant acne despite standard therapies
- Rapid onset or sudden worsening
- Signs of virilization beyond normal male development
- Other symptoms suggesting adrenal or testicular pathology
If congenital adrenal hyperplasia is identified, low-dose glucocorticoid therapy can be beneficial 3. These patients showed improvement with glucocorticoid treatment targeting the underlying hormonal abnormality.
Standard Acne Treatment Algorithm
For mild to moderate acne:
- Topical retinoid (adapalene, tretinoin, or tazarotene) as foundational therapy 4
- Combined with benzoyl peroxide to address inflammation and prevent bacterial resistance 4
- Consider adding topical clascoterone (FDA-approved topical anti-androgen for males and females ≥12 years) 5, 6, 7
For moderate to severe acne:
- Continue topical combination therapy
- Add oral isotretinoin for severe or refractory cases 4
- Oral antibiotics can be used short-term but should be limited due to resistance concerns 8
Topical clascoterone deserves special mention as it provides localized androgen receptor blockade without systemic hormonal effects, making it uniquely suitable for male patients 5, 7. Unlike spironolactone or combined oral contraceptives (which are female-only options), clascoterone can be safely used in men.
Special Populations
Transgender men on testosterone therapy: Acne is extremely common, affecting up to 15.8% within 5 years of testosterone initiation, with highest risk in the first year 9. Risk remains elevated compared to cisgender men even after the first year (HR 5.29) 9.
- Apply standard acne treatment guidelines
- Do not discontinue testosterone to treat acne, as this undermines gender-affirming care
- Monitor closely during the first year of testosterone therapy
- Isotretinoin can be used but requires careful reproductive counseling and contraception assessment
- Consider multidisciplinary coordination with gender-affirming care providers
Men receiving testosterone replacement therapy (TRT): Acne occurs in 0.6-9.1% of men on TRT, varying by formulation 12. Injectable formulations show higher acne rates than topical or oral preparations 12. If acne develops:
- Treat with standard acne therapies first
- Consider formulation change if acne is severe
- Only reduce or discontinue TRT if testosterone levels are supraphysiologic or if underlying hypogonadism was questionable
Treatments NOT Recommended for Men
Spironolactone is contraindicated in men due to:
- Feminizing effects (gynecomastia, breast tenderness)
- Potential feminization of male fetuses if partner becomes pregnant 5
- Lack of evidence in male populations 8, 5
Combined oral contraceptives are obviously not applicable to male patients.
Danazol showed some historical benefit in one case report 13 by suppressing testosterone, but this approach is not recommended as it would cause other hormonal disruptions and is not supported by modern evidence.
Monitoring Considerations
If pathologic androgen excess is identified and treated:
- Monitor clinical response to acne treatment at 3-month intervals
- Reassess hormonal parameters if treating underlying endocrine disorder
- For men on TRT with acne, standard TRT monitoring applies 14
Key Clinical Pitfalls
Do not assume all acne in men is "hormonal" - most male acne occurs with normal testosterone levels and reflects pilosebaceous unit sensitivity 2
Do not withhold isotretinoin from appropriate male candidates due to concerns about hormones - isotretinoin works through retinoid mechanisms, not hormonal pathways
Do not use anti-androgens systemically in men without clear endocrine pathology - the risk-benefit ratio is unfavorable
Do not stop gender-affirming testosterone to treat acne in transgender men - this causes significant harm to mental health and quality of life 10, 11